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Transcriptional Regulatory Cascade for Elastase Production in
Vibrio vulnificus
LuxO ACTIVATES luxT EXPRESSION AND LuxT REPRESSES smcR EXPRESSION*□S
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Vibrio vulnificus causes diseases through actions of various
virulence factors, including the elastase encoded by the vvpE
gene. Through transposon mutagenesis of V. vulnificus, vvpE
expression was shown to be increased by luxO mutation. Since
the vvpE gene is known to be positively regulated by SmcR via
direct binding to the vvpE promoter, the role of LuxO in smcR
expression was investigated. The luxAB-transcriptional fusions
containing different lengths of the smcR promoter region indi-
cated that the smcR transcription was negatively regulated by
LuxO and that a specific upstream region of the smcR gene was
required for this repression. Since LuxO is a known member of
positive regulators, the negative regulation of smcR transcrip-
tion by LuxO prompted us to identify the factor(s) linking LuxO
and smcR transcription. LuxT was isolated in a ligand fishing
experiment using the smcR upstream region as bait, and smcR
expression was increased by luxTmutation. Recombinant LuxT
bound to a specific upstream region of the smcR gene, 154 to
129 relative to the smcR transcription start site. The expres-
sion of luxT was positively regulated by LuxO, and the luxT
promoter region contained a putative LuxO-binding site.
Mutagenesis of the LuxO-binding site in the luxT promoter
region resulted in a loss of transcriptional control by LuxO.
Therefore, this study demonstrates a transcriptional regulatory
cascade for elastase production, where LuxO activates luxT
transcription and LuxT represses smcR transcription.
Vibrio vulnificus is a human pathogen that causes fatal sep-
ticemia with rapid pathogenic progression and high mortality
rates. One of the major virulence factors responsible for this
pathology is an extracellular protease called elastase (1, 2),
which is a 45-kDa zincmetalloprotease of the thermolysin fam-
ily and is encoded by vvpE (3). VvpE enhances vascular perme-
ability, causes hemorrhagic damage, and degrades type IV col-
lagen in the vascular basement membrane, leading to
destruction of the basement membrane and breakdown of cap-
illary vessels (4). Expression of vvpE is induced under the con-
ditions at high cell density, and its regulation is mediated by
sigma factor S, cAMP-(catabolite regulator protein), and SmcR
(5, 6).
SmcR, one of the regulators of vvpE expression, is homolo-
gous toVibrio harveyi LuxR, which is amaster quorum-sensing
regulator (7–9). In related pathogens, Vibrio cholerae, Vibrio
anguillarum, and Vibrio parahemeolyticus, their virulence fac-
tors, such as hemagglutinin/protease, metalloprotease EmpA,
and capsular polysaccharide, are regulated by LuxR homo-
logues, HapR, VanT, andOpaR, respectively (10–13). Fine tun-
ing the expression of these virulence factors is achieved by
modulation of intracellular levels of this transcriptional factor,
LuxR (14). For example, inV. harveyi, the luxR gene is indirectly
repressed by the luxO gene product, which is an NtrC-type
response regulator (15). Interestingly, LuxR synthesis is regu-
lated at the post-transcriptional level in V. harveyi (16). Under
low cell density, a phosphorylated form of LuxO activates the
transcription of sRNA (16), which destabilizes luxR mRNA in
the presence of the RNA chaperone, Hfq. Thus LuxO indirectly
represses LuxR synthesis. The same mechanism is also opera-
tive in repression of hapR expression by four sRNAs in
V. cholerae (16). However, there has been no report yet on the
transcriptional control of luxR-homologous genes via a cell
density-dependent regulatory cascade.
In the present study, we screened a mutant pool of V. vulni-
ficus to isolate regulator(s) of extracellular proteases ofV. vulni-
ficus and obtained a luxO mutant. Investigation of the regula-
tory mechanism explaining the role of LuxO in expression of
elastase revealed a transcriptional repressor of smcR expres-
sion, LuxT, whose expression is activated by LuxO.
EXPERIMENTAL PROCEDURES
Bacterial Strains, Plasmids, and Culture Conditions—The
strains and plasmids used in this study are listed in Table 1.
Escherichia coli strains used for plasmid DNA preparation and
for conjugational transferwere grown in Luria-Bertanimedium
supplemented with appropriate antibiotics at 37 °C. V. vulnifi-
cus strains were grown in AB medium (300 mM NaCl, 50 mM
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MgSO4, 0.2% (w/v) vitamin-free casamino acids, 10 mM potas-
siumphosphate, 1mM L-arginine, 1% (v/v) glycerol, pH 7.5) (17)
at 30 °C, unless stated otherwise. Allmedium components were
purchased from Difco, and the chemicals and antibiotics were
from Sigma.
Construction of Deletion Mutants of V. vulnificus—A
1,190-bpDNAcontaining the luxOupstream regionwas ampli-
fied from the genomic DNA of V. vulnificusMO6–24/O using
two primers, luxO-upF (5-ATTCGTGACTCGAGGCTAGG-
3; underlined sequence denotes an XhoI restriction site) and
luxO-upR (5-CCTCAAGGGATCCGCTCCGC-3; under-
lined sequence denotes a BamHI restriction site). The PCR
product was then cloned into pBluescript SK II() to produce
pSKluxO01. A 592-bp DNA fragment containing the down-
stream region of the luxO gene was made using the primers
luxO-downF (5-ATGGACTTGGATCCGCAAAC-3; under-
lined sequence denotes a BamHI restriction site) and luxO-
downR (5-GCTGACATCTAGATAGCCAG-3; underlined
sequence denotes an XbaI restriction site) and cloned into the
corresponding sites of pSKluxO01 to result in pSKluxO02.
Then a 1.2-kb kanamycin resistance gene was isolated from
pUC4K (Amersham Biosciences) and inserted into the BamHI
site of pSKluxO02 to produce pSKluxO03. A 2,982-bp DNA
fragment of pSKluxO03 digested with XhoI and XbaI was
ligated into a suicide vector, pDM4 (18), to generate pDM4-
luxO. The E. coli SM10pir strain carrying pDM4-luxOwas
conjugated with V. vulnificus MO6–24/O, and the exconju-
gants were then selected on thiosulfate citrate bile sucrose
medium supplemented with 4 g/ml chloramphenicol. Colo-
nies that were positive for double homologous recombination
were selected by resistance to 5% (w/v) sucrose, sensitivity to
chloramphenicol, and resistance to kanamycin. The selected
colony was further confirmed by PCR using primers luxO-upF
and luxO-downR and named KPM201.
A 699-bp PCR product containing the luxT upstream region
was amplified using primers luxT-upF (5-GGGCCCGTCTG-
CAACGTCATCGCCTTC-3; underlined sequence denotes
an ApaI restriction site) and luxT-upR (5-CGGGATCC-
AGCAACTGATCAACAACGGC-3; underlined sequence
denotes a BamHI restriction site) and then cloned into pBlue-
script SKII() to produce pSKluxT01. A 1,446-bp PCRproduct
wasmade to contain the downstream region of luxT gene using
luxT-downF (5-CGGGATCCAAGCTGGGTTGTTGCGT-
TGG-3; underlined sequence denotes a BamHI restriction
site) and luxT-downR (5-GCTCTAGACCATGGCGCT-
GAATGCACTAC-3; underlined sequence denotes an XbaI
restriction site) and cloned into the corresponding sites of pSK-
luxT01 to produce pSKluxT02. nptI encoding a kanamycin
resistance enzyme was isolated from pUC4K (Amersham Bio-
sciences) and inserted into pSKluxT02 to generate pSKluxT03.
The ApaI-XbaI DNA fragment of pSKluxT03 was ligated into
pDM4 (18) to produce pDM4-luxT. The resultant plasmid in
E. coli SM10pir strain was mobilized to V. vulnificus MO6–
24/O, and the exconjugants were selected. Colonies with char-
acteristics indicating a double homologous recombination
event were isolated as described above (19). Deletion of the
luxT gene in candidate colonies was confirmed by PCR with
primers luxT-upF and luxT-downR and was named SM301.
Azocasein Assay for Exoprotease Activity—Total exoprotease
activity of V. vulnificuswas measured by monitoring the extent
of azocasein degradation upon incubation with the spent
medium ofV. vulnificus as described (20). One hundred fiftyl
of azocasein solution (20 mg/ml) was mixed with an equal vol-
ume of cell-free supernatants of V. vulnificus cultures and then
incubated at 37 °C for 1 h. The amount of the released azo dye
was determined by measuring absorbance at 440 nm with a
spectrophotometer.
Zymographic Analysis for Elastase Activity—V. vulnificus
MO6–24/O and mutant strains were freshly grown in the AB
medium at 30 °C for 3 h. The luxO mutant strains carrying
pRK415-based plasmids were freshly grown in the ABmedium
supplemented with 3 g/ml tetracycline at 30 °C for 3.5 h.
Twenty l of each cell-free supernatant, which was mixed with
nonreducing Laemmli sample buffer without heat denatur-
ation, was loaded on a 12% (w/v) denaturing polyacrylamide gel
copolymerized with 0.3% (w/v) gelatin as described (21). To
estimate the protein contents in cell-free supernatants, each
sample was treated with 10% (w/v) trichloroacetic acid, and
then the total protein amount was measured using a Bradford
assay kit (Bio-Rad). An equal amount of protein was used for
each cell-free supernatant. Each cell-free supernatant can be
seen to include almost the same amount of protein.
Site-directed Mutagenesis of the luxT Promoter—Based on
the consensus sequence (TTGCAN3TGCAA) proposed by
Lenz et al. (16), a putative LuxO-binding site, TTGCACCTAG-
CAA, was found in the luxT promoter region between 312
and300 relative to the initiation codon of the luxT gene. This
site wasmutagenized usingGeneEditorTM in vitro site-directed
mutagenesis kit (Promega). A DNA fragment containing the
luxT promoter region in the pLuxT-675 (see the below) was
cloned to pGEM-11zf() to produce pGEM-11zf()-675.
Then, luxT-siteF (5-GTTATCACAGTGAGTGAGCCAT-
GCCTAGCAAGATTTTATAA-3; underlined bases repre-
sent the site for mutagenesis) was used to substitute five bases
in the binding site, which resulted in change of TTGCA to
CCATG in the putative LuxO-binding site. The resultant plas-
mid with the mutated LuxO-binding site was named
pGEM-11zf()-675mt.
Construction of Transcriptional Fusions—To monitor the
expression of the smcR gene, the smcR promoter region was
amplified and used to construct transcriptional fusions
between the smcR promoter and the luxAB gene. The promoter
region was previously identified and shown to contain a single
transcription start site (6). The smcR promoter encompassing
nucleotides 517 and 126 (relative to the transcriptional
start site of the smcR gene) was amplified from the genomic
DNAofV. vulnificususing primers, smcR-nbs (5-GGGGTAC-
CATTACCGAGCTAGGAAGCCG-3; underlined sequence
denotes a KpnI restriction site) and smcR-down2 (5-
GCTCTAGAAGATAAGCGAGTTCGCGG-3; underlined
sequence denotes an XbaI restriction site). A smaller smcR pro-
moter containing nucleotides 48 to 126 (relative to the
transcriptional start site of the smcR gene)was also amplified by
PCR using primers smcR-up3 (5-GGGGTACCTCACCATA-
AGTTATTGACCC-3; underlined sequence denotes a KpnI
Role of LuxO and LuxT in smcR Expression
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restriction site) and SmcR-down2. Each DNA fragment was
digested by KpnI and XbaI, and ligated to KpnI/XbaI-digested
pHK0011, which contained the promoterless luxAB genes (22).
The resultant plasmids, pSmcR-517 andpSmcR-48,weremobi-
lized into V. vulnificusMO6–24/O, luxOmutant, and luxT
mutant by conjugation. Exconjugant V. vulnificus harboring
one of the fusion plasmids were grown in AB medium supple-
mented with 3 g/ml tetracycline.
A DNA fragment containing the luxT promoter region from
675 to118 relative to translation initiation codon of the luxT
gene was amplified from the genomic DNA of wild type V. vulni-
ficus using primers luxT-fusF (5-GGGGTACCTTGGCAAAT-
TCCGCTTGTAGC-3; underlined sequence denotes a KpnI
restriction site) and luxT-fusR (5-GCTCTAGAGTTGACT-
CAACGTCGTGTACG-3; underlined sequencedenotes anXbaI
restriction site). Another DNA fragment having the same size of
luxTpromoter region, butwith amutagenizedLuxO-binding site,
wasprepared fromplasmidpGEM-11zf()-675mtusing the same
primers. Each DNA fragment was digested by KpnI and XbaI and
ligated to KpnI/XbaI-digested pHK0011 (22). The resultant plas-
mids, pLuxT-675andpLuxT-675mt,have the luxTpromoterwith
a wild type LuxO-binding site and mutant LuxO-binding site,
respectively. Theyweremobilized intowild type orluxOmutant
V. vulnificusbyconjugation, and theexconjugantswere selected in
thiosulfate citrate bile sucrose medium supplemented with 3
g/ml tetracycline.
The light produced by these cells was measured in the pres-
ence of 0.006% (v/v) n-decylaldehyde using a luminometer
(TD-20/20 Luminometer, Turners Designs). Specific biolumi-
nescence was calculated by normalizing the relative light units
with respect to cell mass (A600) as described (23).
Western Blot Analysis of SmcR—Cell lysates of wild type,
luxO, luxT, and smcR V. vulnificus strains were prepared by
sonication in TNT buffer (10 mM Tris-HCl, pH 8.0, 150 mM
NaCl, 0.05% (v/v) Tween 20) (24). Eighty g of each bacterial
lysate was fractionated by SDS-PAGE and transferred to a
Hybond P membrane (Amersham Biosciences). The mem-
brane was incubated with polyclonal antibodies against SmcR
(1:5,000, v/v) and then with alkaline phosphatase-conjugated
rabbit anti-rat IgG (1:1,000, v/v; Sigma). Immunoreactive pro-
tein bands were visualized using the nitro blue tetrazolium/5-
bromo-4-chloro-3-indolyl phosphate system (Promega).
Ligand Fishing for Protein(s) Bound to the smcR Promoter—
The DNA fragment used as bait was amplified with primers
smcR-F1 (5-biotin-CTAATTCACGAACTCGTTCC-3) and
smcR-R1 (5-AATGGTGCATATGCATTGGG-3), which
contained the 357-bp promoter region of the smcR gene. As a
control DNA, the 374-bp coding region of the smcR was made
with two primers, smcR-F2 (5-biotin-TTTGCTCGTCGTG-
GCATTGG-3) and smcR-R2 (5-ACTTCACCACGCT-
CAATGGC-3). Fifty g of amplified DNA was loaded onto a
NeutraAvidin column as directed by themanufacturer (Pierce).
Wild type V. vulnificus cells harvested at A600 of 0.1 were pro-
cessed as described previously (25). Proteins eluted from each
columnwere subjected to SDS-PAGE, and the protein bands of
interest were excised from the gel and treated as described (25).
TABLE 1
Strains and plasmids used in this study
Strain/Plasmid Relevant characteristics Reference/Source
Strains
V. vulnificus
MO6-24/O Clinical isolate Ref. 41
QJR70-1 MO6–24/O, luxO::mini-Tn5 lacZ1-KmR This study
KPM201 MO6–24/O, luxO, KmR This study
HS03 ATCC29307, smcR, KmR Ref. 5
SM301 MO6–24/O, luxT, KmR This study
KC64 ATCC29307, vvpE Ref. 1
E. coli
DH5 f80dlacZ DM15 recA1 endA1 gyrA96 relA1 thi-1 hsdR17(rKmK) supE44 deoR (lacZYA-argF)U169 Laboratory collection
SM10pir thi-1 thr leu tonA lacY supE recA::Rp4–2-Tc::Mu pir;KmR Ref. 42
JM109 endA1 recA1 gyrA96 thi-1 hsdR17(rKmK) relA1 supE44 (lac-proAB)FtraD3 6proAB lacIqZM15 Promega
BMH71-18mutS thi supE (lac-proAB), mutS:Tn10 FproAB lacIqZM15 Promega
Plasmids
pHK0011 pRK415 with promoterless luxAB, TcR Ref. 22
pHS201 vvpE::luxAB transcriptional fusion in pHK0011, TcR Ref. 5
pSmcR-517 smcR::luxAB transcriptional fusion in pHK0011, TcR (517 to126) This study
pSmcR-48 smcR::luxAB transcriptional fusion in pHK0011, TcR (48 to126) This study
pGEM-11Zf() General cloning vector, ApR Promega
pGEM-11Zf()-675 pGEM-11Zf() with upstream region of luxT, ApR This study
pGEM-11Zf()-675mt pGEM-11Zf()-675, but with mutation in the putative LuxO-binding site, ApR This study
pLuxT-675 luxT::luxAB transcriptional fusion in pHK0011, TcR This study
pLuxT-675 mt pLuxT-675, but with mutation in the putative LuxO-binding site, TcR This study
pBluescript II SK() Cloning vector; ApR, lac promoter (lacZ), f1, ColE1 Stratagene
pUC4K pUC4 with nptI, ApR, KmR Amersham Biosciences
pDM4 Suicide vector; oriR6K, CmR Ref. 18
pSKluxO01 pBluescript II SK() with 1,190 bp upstream region of luxO, ApR This study
pSKluxO02 pSKluxO01 with 592 bp downstream region of luxO, ApR This study
pSKluxO03 pSKluxO02 with 1.2-kb nptl gene, ApR, KmR This study
pDM4-luxO pDM4 containing XhoI and XbaI fragment of pSKluxO03, CmR, KmR This study
pLAFR5 IncP TcR, derivative of pLAFR3 containing a double cos cassette Ref. 43
pLAFR5-luxO pLAFR5 with 2,135-bp V. vulnificus luxO, TcR This study
pSKluxT01 pBluescript II SK() with 699-bp upstream region of luxT, ApR This study
pSKluxT02 pSKluxT01 with 1,466-bp downstream region of luxT, ApR This study
pSKluxT03 pSKluxT02 with 1.2-kb nptl gene, ApR, KmR This study
pDM4-luxT pDM4 containing ApaI and XbaI fragment of pSKluxT03, CmR , KmR This study
pQE30 Expression vector, ApR Qiagen
pQE-luxT pQE30 containing 471-bp V. vulnificus luxT coding region, ApR This study
Role of LuxO and LuxT in smcR Expression
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The resultant peptides were subjected to matrix-assisted laser
desorption ionization-time of flight (MALDI-TOF)3 mass
spectrum analysis using a Voyager-DE STR (Applied Biosys-
tems Inc.).
Purification of Recombinant LuxT—Two oligonucleotides,
luxT-overF (5-CGCGGATCCATGCCAAAGCGTAGTAAA-
GAAGATACC-3; underlined sequence denotes a BamHI
restriction site) and luxT-overR (5-GGGCTGCAGTATTG-
GTCGTTATTGACTAATACG-3; underlined sequence
denotes a PstI restriction site), were used to amplify a 471-bp
DNA fragment containing the complete open reading frame of
the luxT gene from the genomic DNA of V. vulnificus. BamHI
and PstI sites located at both ends of the resultant luxT DNA
were used to clone this DNA into the pQE30 expression plas-
mid (Qiagen), to generate a plasmid pQE-luxT. Recombinant
LuxT was overexpressed in E. coli JM109 by adding isopropyl-
thio--D-galactoside (Sigma) at a concentration of 1.0 mM, and
purified using an Ni-nitrilotriacetic acid affinity column as
directed by the manufacturer (Qiagen). In the eluted fractions
of the Ni-nitrilotriacetic acid chromatography, the recombi-
nant LuxTappeared to be a single protein of a high purity, based
upon an image of stained protein separated by SDS-PAGE (sup-
plemental Fig. 1).
Gel Shift Assay—Two primers, smcR-comF (5-CCAAGC-
TTTCAATACGCAAACGTTCACC-3) and smcR-down2 (5-
GCTCTAGAAGATAAGCGAGTTCGCGG-3), were used to
amplify a 367-bp fragment of the smcR promoter region. The
DNA fragment was labeled with [-32P]ATP using T4 polynu-
cleotide kinase, and 7 nM was included for each binding assay
(24). Binding reactions were carried out in a reaction buffer
containing 40 mM HEPES-KOH, pH 7.9, 400 mM KCl, 10 mM
MgCl2, 2 mM dithiothreitol, 10% (v/v) glycerol, and 1 g of
poly(dI-dC) (Sigma). Two different concentrations of recombi-
nant LuxT were used, 100 and 200 nM. The binding mixture
incubated for 30min at 37 °Cwas then separated on a 6% native
polyacrylamide gel. For competition analysis, the same, but
unlabeled, smcR promoter DNAwas added to the binding reac-
tion in a 10- and 30-fold molar excess of the labeled probe. A
378-bp DNA of the gap (glyceraldehyde-3-phosphate dehydro-
genase) promoter region was amplified from V. vulnificus by
PCR with primers, gap-F (5-GGGGTACCGGAATGTAAG-
CATGCTACCACACC-3), and gap-R (5-GGGAATTCCAT-
GGTCTATTCCCTAATGATTCA-3), and an 200 nM con-
centration of this DNA fragment was used as a nonspecific
control DNA in the competition experiment.
DNase I Footprinting Assay—A367-bp DNA fragment of the
smcR promoter region was amplified by PCR using labeled
smcR-down2 primer and unlabeled smcR-comF primer. The
binding of recombinant LuxT protein (100, 200, 400, and 800
nM) to the labeled smcR promoter (3 nM) was performed for 30
min at 37 °C in a reaction buffer containing 40 mM HEPES-
KOH, pH 7.9, 400 mM KCl, 10 mM MgCl2, 2 mM dithiothreitol,
10% (v/v) glycerol, and 1 g of poly(dI-dC) (Sigma). The reac-
tion mixture was treated with DNase I for 1 min at room tem-
perature andwas terminatedwith stop buffer (10mMTris-HCl,
20 mM NaCl, 20 mM EDTA, 0.2% (w/v) SDS, and 100 g of
tRNA). After precipitation with ethanol, the digested DNA
products were resolved by a 4% polyacrylamide sequencing gel
alongside sequencing ladders (24). Sequencing ladders were
generated from pSmcR-517, a plasmid containing the smcR
promoter region (Table 1), using labeled smcR-down2 primer
and the AccuPower DNA sequencing kit (Bioneer).
Statistical Analyses—Results were expressed as the mean 
S.D. from three independent experiments. Statistical analysis
was performed using Student’s t test (SYSTAT program, Sig-
maPlot version 9; Systat Software Inc.). Differences are consid-
ered significant if p values were 	0.01. Data with a p value of
	0.001 are indicated with two asterisks, whereas data with a p
value between 0.001 and 0.01 are represented with one asterisk.
RESULTS
Isolation of a Mutant Showing Increased Exoproteolytic
Activity—To isolate factors involved in production of exopro-
tease(s) in V. vulnificus, we screened 10,000 mini-Tn5 lacZ1
V. vulnificus mutants (26) on agar plates containing 1.5% (w/v)
skimmilk.Oneof themutants,QJR70–1,which showedadistinc-
tively larger clear zone around its colony, was selected as a candi-
date for increasedproteolytic activity.ADNAsegment containing
the mini-Tn5 was isolated from the genomic DNA of QJR70–1
using the kanamycin-resistant phenotype encoded by mini-Tn5
3 The abbreviations used are: MALDI-TOF, matrix-assisted laser desorption
ionization time-of-flight.
FIGURE 1. Activity of extracellular proteases produced by wild type and
luxO V. vulnificus, determined by azocasein degradation analysis (A)
and zymographic analysis (B). A, cell-free supernatants of wild type or
luxOmutantwere sampled at exponential phase (A600 of 0.2) and stationary
phase (A600 of 1.5) and tested for their activity to degrade azocasein. The
amounts of the released azo dye due to proteolytic activity of wild type (open
bars) orluxOmutant (closed bars) were determined using a spectrophotom-
eter (20). Data with a p value of 	0.001 (Student’s t test) are indicated with
two asterisks, whereas data with a p value between 0.001 and 0.01 (Student’s
t test) are representedwith an asterisk. B, the cell-free supernatants of various
V. vulnificus strains collected at the exponential phase (A600 of 0.2) were
loaded on a 12% polyacrylamide gel copolymerized with 0.3% (w/v) gelatin.
In-gel proteolytic activities of V. vulnificus were visualized as clear zones in a
gelatin-containinggel uponaCoomassieBrilliant BlueR staining.A clear zone
produced by the elastase (VvpE) is indicated with an arrow. Lane 1, wild type;
lane 2, elastase-deficient vvpE mutant; lane 3, luxO mutant; lane 4 luxO
mutant harboring a broad host range vector, pLAFR5; lane 5, luxO mutant
carrying pLAFR5-luxO.
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lacZ1 (27). Sequence analysis of the flanking regions of the mini-
Tn5 in QJR70–1 revealed that its luxO locus was disrupted (data
not shown). The luxO gene is found to be followed by the luxU
gene,whosegeneproduct is speculated tobeaphosphotransferase
in other Vibrio spp. (15, 28, 29). The genetic organization of this
luxO-U cluster is conserved across other V. vulnificus strains,
YJ016 (GenBankTM accession number NP_933988) and CMCP6
(GenBankTM accession numberNP_761887). The deduced amino
acid sequence of LuxOofV. vulnificus (GenBankTM accession num-
berDQ778302) showed94, 93, 89, and75% identity to thoseofLuxO
proteins of V. parahemeolyticus (GenBankTM accession number
BAC60362),V.harveyi (GenBankTMaccessionnumberAAD12736),
V. cholerae (GenBankTMaccessionnumberQ9KT84), andV. fischeri
(GenBankTM accessionnumberYP_204320), respectively.
Generation of a luxO Deletion Mutant and Determination of
Its Exoprotease Activities—Since the strain QJR70-1 includes
foreign DNA sequence derived from the mini-Tn5 lacZ1 in its
chromosomal DNA, we constructed a luxO deletion mutant
from the wild typeV. vulnificusMO6-24/O to exclude any pos-
sible effect of transposon DNA on exoprotease activities of
V. vulnificus. Two sets of primers were used to construct a
luxOmutant (i.e. a set of two primers specific to the upstream
region and a second set of primers specific to the downstream
region of luxO). The resultant luxO mutant, KPM201, lost a
main portion of the open reading frame of the LuxO protein
from amino acid 103 to 239, and instead had the nptI gene
responsible for resistance to kanamycin. Deletion of the luxO
gene in chromosome of themutantV. vulnificuswas confirmed
by PCR using the primers luxO-upF
and luxO-downR. The resultant
PCR product of the luxO mutant
V. vulnificus appeared to be 3.0 kb,
whereas the intact luxO gene in the
wild type produced a smaller PCR
product of 2.2 kb (data not shown).
Cell-free supernatants of both
wild type MO6–24/O and luxO
mutant KPM201 cultures were eval-
uated for total extracellular protease
activity by measuring their ability to
degrade azocasein. The total exo-
protease activities of the luxO
mutant were about 2 and 1.5 times
higher than those of wild type at the
exponential phase and the station-
ary phase, respectively (Fig. 1A).
These differences were statistically
significant, with p 	 0.001 during
the exponential phase and p	 0.005
during the stationary phase.
Since V. vulnificus secretes sev-
eral kinds of exoproteases (1), it was
necessary to determine which pro-
tease(s) is up-regulated by the luxO
mutation. Therefore, through a
zymographic analysis, exoprotease
profiles of wild type and KPM201
were compared with that of an elas-
tase-minus mutant (vvpE knock-out mutant) (1). Zymography
showed increased elastase activity in the supernatant of
KPM201 (Fig. 1B). Furthermore, elastase activity returned to
normal when the intact luxO gene was supplied to the luxO
mutant using a broad host range vector, pLAFR5, whereas a
control plasmid pLAFR5 did not affect elastase activity of the
luxO mutant. These data suggest that alteration in elastase
activity of KPM201 was due to the luxOmutation.
To verify that the observed change in elastase activity was
attributable to increased vvpE expression gene encoding elas-
tase, the expression of vvpE::luxAB transcriptional fusion (22)
wasmeasured in both the wild type and theluxOmutant. The
vvpE expression during the exponential phase increased2–3-
fold in the luxO mutant compared with wild type (data not
shown). During the stationary phase, however, there was no
difference in vvpE::luxAB expression between the wild type and
the luxO mutant (data not shown). The luxO mutant
showed higher total exoprotease activity than wild type during
the stationary phase (Fig. 1A), indicating that other exopro-
tease(s) may be repressed by LuxO in V. vulnificus.
Effect of luxOMutation on smcRExpression—InV. vulnificus,
expression of the vvpE gene is directly controlled by SmcR, a
LuxR homologue (5, 6). Therefore, we investigated the
mechanism by which LuxO regulates vvpE expression and
the role of SmcR in this process. Wild type and luxO
mutant lysates were examined for intracellular SmcR levels
byWestern blot analysis using polyclonal antibodies that are
specific to recombinant SmcR. luxO mutant cells con-
FIGURE 2.Western blot analysis of SmcR (A) and effect of luxOmutation on smcR expressiondetermined
by estimating the expression of smcR::luxAB transcriptional fusions (B). A, cell lysates of thewild type and
various mutants collected at the exponential phase were used to estimate cellular contents of SmcR protein.
The SmcR protein appeared as an immunoreactive band as indicated with an arrow. Lane 1, a protein size
marker; lane 2, wild type; lane 3, smcRmutant; lane 4, luxOmutant; lane 5, luxTmutant. B, two smcR::luxAB
transcriptional fusionswere constructed. The smcR promoter regions used for fusion reporters encompass the
DNA region of517 to126 and48 to126 (relative to the transcriptional start site for the smcR gene) (6),
and the resultant fusions are designated by pSmcR-517 and pSmcR-48, respectively. Wild type and luxO
mutant-containing pSmcR-48 (a) or pSmcR-517 (b) were grown inmedium supplemented with 3g/ml tetra-
cycline, and aliquots were sampled and determined for their cell masses (A600) and their bioluminescence
(relative light units (RLU)). Luciferase activities are expressed as normalized values, by dividing the relative light
units by the A600 of each sample. The activities of three independent experiments were averaged and pre-
sentedwith their S.D. values. The luciferase activities of smcR::luxAB fusion inwild typeV. vulnificus are denoted
as open circles, whereas those in the luxOmutant are indicated as closed circles.
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tained 5–6 times more SmcR than wild type cells during
exponential phase, based upon densitometric reading of
SmcR bands (Fig. 2A, lanes 2 and 4).
In V. harveyi, LuxR is negatively regulated by LuxO at the
post-transcriptional level via sRNA and Hfq (16), but there is
little information on the transcriptional control of luxR by
LuxO. Here, we examined the transcriptional effect of LuxO
on smcR expression by constructing the two smcR::luxAB
transcriptional fusions with different lengths of the smcR
promoter region (covering 517 to 216 and 48 to 216
nucleotide positions relative to the transcriptional start site
for smcR). Expression of the shorter fusion (pSmcR-48) was
not affected by the mutation at the luxO locus (Fig. 2B, a).
The longer fusion (pSmcR-517), however, showed increased
expression in luxO mutant during the exponential phase
(Fig. 2B, b). This result demonstrated that the LuxO down-
regulates smcR expression at the transcriptional level during
the exponential phase and that repression by LuxO requires
the smcR upstream region between 517 and 49. The
derepressed expression level of pSmcR-517 in luxOmutant
cells was less than that of pSmcR-48 during exponential
phase, suggesting that the smcR upstream region may be
regulated by factors other than LuxO.
Isolation of LuxTasaProteinBound to smcRPromoterRegion—
Since LuxO is a homolog of NtrC, a well known transcriptional
activator (16), the repressive effect of LuxOon smcR expression
is probably indirect. Therefore, we performed an experiment to
isolate the transcriptional factor(s) comprising the regulatory
pathway between LuxO and smcR. Lysate of V. vulnificus was
incubated with a DNA fragment containing the smcR pro-
moter, and bound proteins were then analyzed by SDS-PAGE.
As a control DNA, lysate was incubated with smcR coding
DNA. One 18-kDa protein band specifically bound to the
smcR promoter but not to the smcR coding region (Fig. 3). The
band, which was excised from the gel and analyzed byMALDI-
TOF mass spectrometry, was identified as LuxT (VV21607;
GenBankTM accession numberNP_367477). LuxT is amember
of the TetR family of the transcriptional regulators, which typ-
ically repress the target genes (30). The deduced amino acid
sequence of V. vulnificus LuxT showed 85% identity to those of
LuxT proteins of V. harveyi (GenBankTM accession number
AAK09362) and V. parahemeolyticus (GenBankTM accession
number NP_799930).
Effect of luxT Mutation on smcR Expression—Our results
suggest that LuxO may exert its function as a negative regu-
lator of smcR expression through transcriptional acti-
vation of luxT, which in turn represses smcR. To verify the
functional role of LuxT in expression of smcR of V. vulnifi-
cus, the luxT deletion mutant, SM301, was constructed.
Chromosomal deletion of the luxT gene was confirmed by
PCR using primers luxT-upF and luxT-downR. As expected,
the PCR product from the luxT mutant with a deletion of
the internal region of the luxT gene, but with the nptI gene
instead, was 3.4 kb. Meanwhile,
the intact luxT in the wild type V.
vulnificus produced a 2.3-kb PCR
product using the same primers
(data not shown).
Western blot analysis of SmcR
in the exponential phase V. vulni-
ficus cells showed that wild type
cells produced a low level of SmcR
(Fig. 2A, lane 2). On the other
hand, the luxT mutant, SM301,
contained2–3 times more SmcR
protein than wild type (Fig. 2A,
lane 5), based upon densitometric
reading of each band. The increase
of SmcR in the luxO mutant was
more distinct than in the luxT
mutant (Fig. 2A, lane 4), and the
FIGURE 3. SDS-PAGE of smcR promoter-binding proteins retrieved from
ligand fishing experiments. Two DNA fragments, one containing the pro-
moter region of smcR (PsmcR) and the other encoding the open reading frame
of smcR (ORFsmcR), were amplified by PCR and used as baits for ligand fishing
experiments. The proteins bound to PsmcR or to ORFsmcR were separated by
SDS-PAGE and visualized by Coomassie Brilliant Blue R staining. Lane 1, pro-
teinmaker; lane 2, proteins bound to PsmcR; lane 3, proteins bound toORFsmcR.
The protein band (designated by an arrow), which was specifically bound to
the smcR promoter, was identified as LuxT by MALDI-TOF mass
spectrophotometry.
FIGURE 4. Effect of luxT mutation on smcR expression determined by estimating the expression of
smcR::luxAB transcriptional fusions. Expression of two smcR::luxAB transcriptional fusions, pSmcR-48 (a) and
pSmcR-517 (b), was measured during the exponential phase in luxT mutant (hatched bars) and compared
with those ofwild type (open bars) andluxOmutant (closed bars) under the samegrowth phase. Datamarked
with anasterisk indicate that fusion expressionwas statistically different from that ofwild type cells bearing the
same fusion (Student’s t test; 0.001 	 p 	 0.01). Luciferase activities are expressed as normalized values,
relative light units (RLU) divided by the A600 of each sample. The activities of three independent experiments
were averaged and presented with their S.D. values.
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level of SmcR in the luxO mutant was about 5–6 times
higher than in wild type cells during the same growth phase.
It may suggest that other factor(s) are involved in the LuxO
regulation of smcR.
In addition toWestern blot analysis, the role of LuxT in smcR
expression was investigated using the two smcR::luxAB tran-
scriptional fusions, pSmcR-48 and pSmcR-517. These fusions
were introduced into luxTmutant, and their luciferase activ-
ities were monitored during the exponential phase (Fig. 4). The
luciferase activity of pSmcR-48 was not statistically different in
luxTmutant,luxOmutant, or wild type (Fig. 4a). In the case
of the luciferase activity of the longer fusion, pSmcR-517, it was
significantly increased in theluxTmutant comparedwith that
of wild type (p 	 0.01, Student’s t test) (Fig. 4b). However, the
degree of derepression by luxT mutation was less than that by
luxO mutation, since luxO mutant showed 2 times more
luciferase activity of pSmcR-517 than luxT mutant (Fig. 4b).
This may imply the presence of LuxT-independent mecha-
nism(s) in the LuxO regulation of smcR.
These results suggest that LuxT expression is transcription-
ally mediated by LuxO protein during the exponential phase
and that LuxT then represses transcription of smcR, resulting in
reduced production of the elastase. It is also demonstrated that
repression by LuxT requires the specific upstream region of
smcR (517 to 49 nucleotide position relative to the tran-
scriptional start site of smcR).
Specific Binding of LuxT to the smcRPromoter—Gel shift assays
were performed to confirm whether LuxT directly binds to the
smcR promoter region. The 367-bp smcR promoter region (which
covered from 240 to 126 nucleotide positions relative to the
transcriptional start site of smcR) was labeled with 32P and incu-
bated with the recombinant LuxT protein (Fig. 5A). When the
binding reaction was subjected to a native gel electrophoresis, the
smcRpromoter incubatedwith LuxT at a concentration of 200 nM
appeared as a slowlymoving band. Specificity of binding was con-
firmed by a competition experiment using unlabeled smcR pro-
moter. The addition of excess unlabeled smcR promoter to the
binding reaction decreased the interaction between LuxT and the
32P-labeled smcRpromoterand thus resulted inadisappearanceof
the slowly moving band. In contrast, the complex formation
between LuxT and the labeled smcR promoter was maintained,
although an excess amount of the gap promoter DNA was added
to the reaction as a competitor.
To identify the specific LuxT binding site, DNase I foot-
printing assay was performed. 32P-Labeled smcR promoter
was incubated with increasing amounts of recombinant
LuxT protein, ranging from 100 to 800 nM, and was then
treated with DNase I. As a control, labeled smcR DNA aloneFIGURE 5.Binding of LuxT to the smcRpromoter region. A, a gel shift assay
was performed to confirm the direct interaction between LuxT and smcR
promoter region. A 32P-labeled 367-bp DNA fragment of the smcR promoter
region (PsmcR; 7 nM) wasmixedwith recombinant LuxT. The reactionmixtures
were subjected to a 6%native polyacrylamide gel electrophoresis. The slowly
moving PsmcR was designated as the PsmcR-LuxT complex, whereas the free
DNA was labeled with PsmcR. For competition analysis, the same but unla-
beled smcR promoter DNA was included in the binding reaction. As a non-
competitive and nonspecific DNA, an unlabeled 378-bp DNA containing the
gap promoter (Pgap) was added to the binding reaction in excess. Lane 1,
labeled PsmcRDNAwithout LuxT; lane 2, labeled PsmcRDNAwith 100 nM LuxT;
lane 3, labeledPsmcRDNAwith 200nMLuxT; lane 4, labeledPsmcRDNAwith 200
nM LuxT and 70 nM unlabeled PsmcR DNA; lane 5, labeled PsmcR DNA with 200
nM LuxT and 210 nM unlabeled PsmcRDNA; lane 6, labeled PsmcRDNAwith 200
nM LuxT and 200 nM unlabeled Pgap DNA. B, a DNase I footprinting assay was
performed to localize the LuxT-binding site in the regulatory region of the
smcR gene. The 32P-labeled 367-bp DNA fragment of the smcR promoter
region (3 nM)was incubatedwith increasing amounts of LuxTprotein ranging
from 100 to 800 nM, and the reactions were then treated with DNase I. The
reaction mixtures were resolved on a 4% polyacrylamide sequencing gel
alongside the sequencing ladder derived from the plasmid pSmcR-517. The
protected region of the smcR promoter was illustrated by a vertical line with
the corresponding nucleotide sequences, which are located in nucleotide
positions 154 to 129 relative to the transcription start site of the smcR
gene. Lane 1, DNA without LuxT; lanes 2–5, DNA with recombinant LuxT pro-
tein at 100, 200, 400, and 800 nM, respectively.
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was also treated with DNase I. The DNase I-digested pat-
terns were observed by autoradiography (Fig. 5B). When
LuxT protein was added to the reaction, a portion of the
smcR promoter was protected from DNase I, which was
located between 154 and 129 (5-AGTGCAATACGC-
TATTTACTATCACA-3) with respect to the transcrip-
tional start site of smcR.
Effect of LuxO on luxT Expression—Involvement of LuxO
in repression of the smcR expression and identification of
LuxT as a protein directly bound
to the smcR promoter led us to
determine the hierarchical order of
LuxO and LuxT in regulating smcR
expression.TheDNAsequenceof the
luxTupstreamregion shows thepres-
ence of the putative LuxO-binding
site (TTGCAN3TGCAA) (16)
between 312 and 300 nucleotide
positions relative to the translation
initiation codon for the luxT gene
(Fig. 6A). The luxT upstream region
including this site was used to con-
struct a transcriptional fusion with
the luxAB genes (pLuxT-675), and its
expression was monitored in both
wild type andluxOmutant. Expres-
sion of pLuxT-675 was maximal
when the bacterial cells entered the
stationaryphase inbothwild type and
luxO mutant. Its expression in the
luxO mutant was less than in wild
type (Fig. 6B, a). The luxO mutation
caused reduction of luxT::luxAB
activity up to one-third of that in wild
type cells during the exponential
phase.
The role of LuxO as an activator
of luxT expressionwas confirmed in
an additional experiment using a
mutagenized LuxO-binding site.
Another luxT::luxAB transcrip-
tional fusion was made, which
included the same luxT upstream
region as in pLuxT-675 but con-
tained the mutagenized LuxO-
binding site (pLuxT-675mt). The
degreeof expressionof pLuxT-675mt
inwild typecellswascomparablewith
that in the luxO mutant. The
expression of the mutagenized luxT
promoter (pLuxT-675mt) was basi-
cally the same as the expression of
the intact luxT promoter (pLuxT-
675) in luxO mutant (Fig. 6B, b).
These results indicate that the
mutated luxT promoter is no longer
influenced by LuxO and therefore
suggest that LuxO may activate luxT
transcription by specifically binding to the luxT upstream region
from312 to300.
DISCUSSION
Extracellular enzymes, such as proteases and phospho-
lipases, that are produced by pathogenic bacteria are involved
in pathogenesis (2, 31, 32). Zymographic analysis of extracellu-
lar proteases secreted from the pathogenicV. vulnificus showed
that themajor proteolytic activity was derived from the elastase
FIGURE 6. Nucleotide sequence of the upstream region of luxT gene (A) and expression of luxT::luxAB
transcriptional fusions (B). A, the initiation codon and Shine-Dalgarno sequence (S/D) of the luxT gene are
underlined. The putative 24/12 RpoN-binding site is italicized, and its putative transcription start site is
denoted by 1. The upstream region of the luxT gene shows the presence of a putative LuxO-binding site,
which was denoted by a box. It is highly similar to the consensus sequence, TTGCAN3TGCAA, suggested by
Lenz et al. (16), anddots show thenucleotides thatmatch the consensus sequence. Thenucleotides changed in
the mutated LuxO-binding sites are shown above the putative LuxO-binding site of the luxT promoter region.
The horizontal arrows indicate the positions of two primers used to construct the luxT::luxAB transcriptional
fusion pLuxT-675. The other fusion, pLuxT-675mt, includes the same region of the luxT in pLuxT-675 but
contains the site-directedmutagenized LuxO-binding site. B, the wild type andluxOmutant carrying pLuxT-
675 (a) or pLuxT-675mt (b) were grown inmedium supplementedwith 3g/ml tetracycline andmeasured for
their luciferase activity. Luciferase activities of luxT::luxAB fusions in wild type are denoted as open circles,
whereas those in the luxOmutant are indicated as closed circles.
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that is encoded by the vvpE gene.4 Despite the ambiguous role
of elastase in bacterial toxicity to mice (1), it is able to degrade
human vascular basement membrane and capillary vessel (4)
and thus is considered as one of the major virulence factors
produced byV. vulnificus (3). Additionally, elastase production
is dependent upon cell density and is controlled by SmcR (22).
There is little information on the quorum-sensing regulation in
V. vulnificus compared with other Vibrio spp. Autoinducer-2
(AI-2) is a quorum-sensingmolecule found inV. vulnificus, which
is able to induce vvpE expression (33). The key regulator for vvpE
expression, SmcR, is a LuxRhomolog, which is awell known tran-
scription factor in quorum-sensing control (7, 8). Therefore, elas-
taseproduction is theonlyknownphenotyperegulatedbyquorum
sensing inV. vulnificus. In thepresent study,we screenedamutant
pool to isolate regulator(s) for production of exoproteases in
V. vulnificus and obtained a luxOmutant. The finding of LuxO as
a regulator for the elastase stimulated us to study the quorum-
sensing regulatory cascade inV. vulnificus and compare the regu-
latory characteristics found in other bacteria.
LuxR is a transcription factor that regulates genes related to
cell density-dependent phenotypes, such as light production in
luminous bacteria and virulence factor production in patho-
genic bacteria. Synthesis of thismaster regulator inV. harveyi is
regulated by LuxO, which is an NtrC-type response regulator
(15).WhenLuxO is phosphorylated, it becomes active in down-
regulation of luxR expression. The effect of LuxO on luxR
expression was assumed to be indirect, since phospho-LuxO
acts as a transcriptional activator in conjunction with sigma
factorN (RpoN) (34, 35). InV. harveyi, binding of sRNA to luxR
mRNA destabilizes the mRNA, and thus regulation of luxR
expression occurs at the post-transcriptional level (16). Here, in
experiments using smcR::luxAB transcriptional fusions, LuxO
was found to repress smcR expression at the transcriptional
level in V. vulnificus (Fig. 2B). Since LuxO putatively activates
RpoN-driven transcription, the derepressing effect of luxO
mutation on smcR transcription suggests that LuxO may indi-
rectly regulate smcR expression via an unidentified regulator.
Therefore, through a ligand fishing experiment, we sought a
transcriptional regulator connecting LuxO activation and smcR
repression (Fig. 3).We identified LuxT as a transcriptional reg-
ulator of smcR expression in V. vulnificus. Expression of the
luxT gene was activated by LuxO (Fig. 6B), and the resultant
LuxT repressed the expression of smcR gene (Fig. 4b). Thus,
these results add LuxT protein to the list of components com-
prising a regulatory cascade for elastase production (Fig. 7).
Discovery of LuxO as a regulator of luxT expression in
V. vulnificus is interesting, since LuxT has been previously
found to regulate the luxO expression in V. harveyi (36, 37). A
genetic approach using site-directed mutagenesis showed that
LuxO appeared to directly control the expression of luxT in V.
vulnificus. The putative LuxO-binding site, proposed by
Bassler’s group (16) is discernable on the luxT upstream region
(Fig. 6A), and mutagenesis of this site abolished the regulatory
effect of LuxO (Fig. 6B). Therefore, the nucleotide sequences in
the luxT promoter, TTGCACCTAGCAA (from 312 to 300 bp
upstream of the luxT gene), might be responsible for binding of
LuxO. In addition, luxT expression is severely impaired in the
rpoNmutant V. vulnificus.5
Based on the result of gel shift assays of smcR promoter with
LuxT protein, we have shown that LuxT plays a role in the
expression of smcR by directly interacting with the smcR pro-
moter (Fig. 5A). In addition, the LuxT binding site in the smcR
promoter region was identified by a DNase I protection assay
(Fig. 5B), and localized to nucleotides154 to129 relative to
the transcriptional start site for the smcR gene. In V. harveyi,
LuxT was shown to bind to the luxO upstream region, and a
potential binding site of LuxT was proposed as a sequence
including the repeats of GTT(T/G)A (37). However, we found
no such consensus sequence in the region of the smcRpromoter
that was protected by LuxT. Whether the repression of luxR
genes by LuxT is common in other Vibrio species or whether
LuxT also regulates luxO expression in V. vulnificus is
unknown.Comparative analyses on the role of LuxTproteins in
quorum sensing signal cascade in various Vibrio species needs
to be done in the future.
The presence of putative sRNA sequences, which showed
high similarity to sRNAs found in V. harveyi and V. cholerae,
has been also proposed in V. vulnificus (16). In fact, deletion of
the hfq gene in V. vulnificus resulted in increased expression of
smcR,6 which suggests that sRNA and Hfq are also involved in
smcR expression at the post-transcriptional level, as found in
4 J.-B. Roh and K.-H. Lee, unpublished data.
5 M.-A. Lee, H.-S. Kim, and K.-H. Lee, unpublished data.
6 S.-M. Kim, M.-A. Lee, and K.-H. Lee, unpublished data.
FIGURE 7. Scheme of the regulatory cascade for elastase production inV.
vulnificus. LuxO and sigma factor N (N) activate luxT transcription. LuxT
represses smcR transcription via a direct binding to the upstream region of
the smcR gene. Then SmcR induces expression of the vvpE gene encoding an
elastase (5). In addition to involvement of LuxT in regulation of smcR expres-
sion, smcR transcription appears to be regulated by unknown factor(s), which
are also induced by LuxO. Hfq negatively regulates smcR expression, possibly
at the post-transcriptional level with small RNAs (16).
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V. harveyi and V. cholerae. In addition to regulation by LuxT
andHfq, it seems that other transcriptional regulators for smcR
expressionmay be present inV. vulnificus (Fig. 7). The findings
of higher expression of the smcR gene in luxOmutant than in
luxT mutant, as determined by Western blot (Fig. 2A) and
transcriptional fusion assay (Fig. 4b), may imply the presence
of LuxT-independent mechanism(s) in the LuxO regulation of
smcR. In V. cholerae and V. anguillarum, the expression of
hapR and vanT is found to be autoregulated (38, 39). Recently,
VqmA protein was found to activate hapR expression, but the
effect of VqmA on hapR is independent of LuxO (40). There-
fore, it remains for further studies to elucidate both mecha-
nisms regulating smcR expression and roles of the VvpE regu-
latory cascade for V. vulnificus pathogenicity.
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